Estimation of XDR-TB in European part of the Russian Federation

Vadim Testov (Fryazino, Moscow Region, Russian Federation), Vadim Testov, Irina Vasilyeva, Vladimir Puzanov, Anastasia Samoilova, Victor Punga

Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Session: Rifampicin resistance, MDRTB, and new drug treatments
Session type: Poster Discussion
Number: 1905
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vadim Testov (Fryazino, Moscow Region, Russian Federation), Vadim Testov, Irina Vasilyeva, Vladimir Puzanov, Anastasia Samoilova, Victor Punga. Estimation of XDR-TB in European part of the Russian Federation. Eur Respir J 2016; 48: Suppl. 60, 1905

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?
Source: Eur Respir J 2012; 39: 619-625
Year: 2012



XDR-TB prevalence in some regions of the Russian Federation
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017


The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Tuberculosis in children of Belarus
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013


Breast tuberculosis in East London
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016

Extensively drug-resistant tuberculosis in the penitentiary facilities of the Russian Federation
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018




Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Risk factors associated with fluoroquinolones-resistance of M.tuberculosis in Novosibirsk Oblast, Russian Federation: Results of retrospective cohort study
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Tuberculosis treatment completion in migrants, St.-Petersburg, Russian Federation
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011

The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

European Union Standards for Tuberculosis Care
Source: Eur Respir J 2012; 39: 807-819
Year: 2012



Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes
Source: Eur Respir J, 52 (6) 1801449; 10.1183/13993003.01449-2018
Year: 2018



European framework for tuberculosis control and elimination in countries with a low incidence: Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis
Source: Eur Respir J 2002; 19: 765-775
Year: 2002



Drug resistance among new TB cases in some Russian regions
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Tuberculosis (TB) in homeless population in Poland
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Characteristics of non-resident new TB cases in Moscow City, Russia
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Drug-resistant tuberculosis in the European Union and European economic area
Source: International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Year: 2015